European Transcranial Dopplers (TCD) Market
- Report Code: TR 1002
- Publish Date: Upcoming
Transcranial doppler (TCD) ultrasound systems are non-invasive methods, used to examine the blood circulation within the brain. It is most commonly used to monitor the blood flow in the brain during surgeries. Europe has been observed to have a high incidence of mental and neurological disorders in the form of epilepsy, and brain tumor among others. The aging population, and the resultant high incidence of brain/mental disorders, is considered as the main market driver for the European transcranial doppler market.
In 2013, the European market accounted a share of 6.03% in the global transcranial doppler market, and is considered as the third largest region in this market segment. The European market is projected to grow at a CAGR of 5.1%, from 2013 to 2018. Countries in the European region such as Germany and France are the main contributors of this market. Emboli detection, subarachnoid hemorrhage, and intracranial stenosis, among others are the main application segments of the TCD market in Europe. Healthcare expenditure is one of the most important macroeconomic factors impacting the growth of the concerned market.
The European region has a vast majority of aging population, and as a result, the demand for healthcare devices has been growing significantly. In addition to this, the rising incidence of brain and mental disorders have been on the rise in this region, along with research reports stating that nearly one-fifth of the total European population is currently suffering from mental disorders, such as epilepsy and narcolepsy. Another major reason for the high demand for TCD and other brain monitoring devices in this region is the ‘patent cliff’ that the companies in the region have arrived at. Some of the major companies operating in the region and contributing towards the growth of the European TCD market include Spiegelberg GmbH & Co. KG (Germany), Elekta (Swededn), and Covidien (Ireland) among others.
The European transcranial doppler market report provides market segmentation with respect to geography and application. The report offers an insightful outlook of the topmost companies thriving in this market, along with detailed information on market share, value chain analysis, and varied market metrics. Germany, France, and the U.K., among others are the main countries that have been considered for this extensive market analysis. In terms of applications, the market has been segmented into emboli detection, subarachnoid hemorrhage, intracranial stenosis, and sickle cell disease among others.
1 Introduction
1.1 Objective of the study
1.2 Market Definitions
1.3 Market Segmentation & Aspects Covered
1.4 Research Methodology
1.4.1 Assumptions (Market Size, Forecast, etc)
2 Executive Summary
3 Market Overview
Please fill in the form below to receive a free copy of the Summary of this Report
Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
| PRODUCT TITLE | PUBLISHED | |
|---|---|---|
|
|
North American Brain Monitoring Devices The North American Brain Monitoring Devices Market, mainly driven by rising incidences of autoimmune and cardiovascular diseases, brain disorders and sleep disorders which was valued at $1119.6 million in 2012 and is poised to grow at a CAGR of 9.0% to reach $1834.0 million by 2018. North American Brain Monitoring Devices market segmented by product such as Electroencephalograph, Transcranial Doppler, Magnetoencephalograph, Intracranial Pressure Monitor, Cerebral Oximeter, and Acessories. The major players extensively covered in this report are Nihon Kohden Corporation, Nonin Medical Inc, Elekta AB, Yokogawa, Grass Technologies, Compumedics Ltd, Cadwell Laboratories |
Upcoming |
|
|
European Brain Monitoring Devices The European Brain monitoring Devices Market, mainly driven by rising incidences of autoimmune and cardiovascular diseases, brain disorders and sleep disorders. The European Brain monitoring market was valued at $279.9 million in 2012 and is poised to grow at a CAGR of 8.6% to reach $458.5 million by 2018. The European Brain monitoring Devices market segmented by product such as Electroencephalograph, Transcranial Doppler, Magnetoencephalograph, Intracranial Pressure Monitor, Cerebral Oximeter, and Acessories. The main companies operating in Brain monitoring devices market and extensively covered in this report are Nihon Kohden Corporation, Nonin Medical Inc, Elekta AB, and Advanced Brain monitoring, Inc., Yokogawa, Grass Technologies, Compumedics Ltd, Cadwell Laboratories |
Upcoming |
|
|
Asian Brain Monitoring Devices The Asian Brain Monitoring Devices Market, mainly driven by rising incidences of autoimmune and cardiovascular diseases, brain disorders and sleep disorders. The Asian brain monitoring market was valued at $162.3 million in 2012 and is poised to grow at a CAGR of 9.2% to reach $275.1 million by 2018. The Asian Brain Monitoring Devices market segmented by product such as Electroencephalograph, Transcranial Doppler, Magnetoencephalograph, Intracranial Pressure Monitor, Cerebral Oximeter, and Acessories. The main companies operating in the Asian brain monitoring devices market and extensively covered in this report are Nihon Kohden Corporation, Nonin Medical Inc, Elekta AB, and Advanced Brain Monitoring, Inc., Yokogawa, Grass Technologies, Compumedics Ltd, Cadwell Laboratories |
Upcoming |
